THE USA JOURNALS
THE AMERICAN JOURNAL OF VETERINARY SCIENCES AND WILDLIFE DISCOVERY
(ISSN
–
2689-0968)
VOLUME 06 ISSUE04
7
https://www.theamericanjournals.com/index.php/tajvswd
PUBLISHED DATE: - 01-08-2024
PAGE NO.: - 7-13
THE ROLE OF DIETARY SUPPLEMENTS IN
MANAGING OSTEOARTHRITIS IN DOGS
Elena Amato
Department of Veterinary Medicine andAnimal Production, University of NapoliFederico II,
Naples, Italy
INTRODUCTION
Osteoarthritis (OA) is a chronic, progressive joint
disease characterized by the degeneration of
cartilage and the underlying bone within a joint,
leading to pain, stiffness, and impaired movement.
It is one of the most common causes of chronic pain
in dogs, significantly impacting their quality of life
and mobility. Traditional management strategies
for canine osteoarthritis primarily involve
pharmacological treatments such as nonsteroidal
anti-inflammatory drugs (NSAIDs), physical
therapy, and weight management. While these
approaches can be effective, they often come with
side effects and may not fully address the long-term
needs of affected dogs.
In recent years, there has been growing interest in
the potential role of dietary supplements as a
RESEARCH ARTICLE
Open Access
Abstract
THE USA JOURNALS
THE AMERICAN JOURNAL OF VETERINARY SCIENCES AND WILDLIFE DISCOVERY
(ISSN
–
2689-0968)
VOLUME 06 ISSUE04
8
https://www.theamericanjournals.com/index.php/tajvswd
complementary
therapy
for
managing
osteoarthritis in dogs. Nutritional supplements,
including glucosamine, chondroitin sulfate, and
omega-3 fatty acids, have been shown to support
joint health by promoting cartilage repair, reducing
inflammation, and enhancing overall joint function.
These supplements offer a promising alternative
for managing OA symptoms with a potentially
lower risk of adverse effects compared to
conventional pharmaceutical treatments.
This study aims to evaluate the efficacy of a specific
combination of dietary supplements in alleviating
the symptoms of osteoarthritis in dogs. By
comparing the clinical outcomes of dogs receiving
the dietary supplement with those receiving a
placebo, this research seeks to determine the
potential benefits of incorporating nutritional
interventions into the standard management
protocol for canine osteoarthritis.
Understanding the impact of dietary supplements
on canine osteoarthritis is crucial for developing
holistic and sustainable treatment strategies. By
providing a safer and potentially more effective
alternative to traditional therapies, dietary
supplements could play a significant role in
improving the quality of life for dogs suffering from
this debilitating condition. This study contributes
to the growing div of evidence supporting the use
of nutritional supplements in veterinary medicine
and offers valuable insights for veterinarians and
pet owners seeking to optimize the health and well-
being of their canine companions.
METHOD
This study was designed as a randomized, double-
blind, placebo-controlled trial to evaluate the
efficacy of dietary supplements in managing
osteoarthritis in dogs. The trial lasted for 12 weeks
and involved two groups: a treatment group
receiving a combination of dietary supplements
and a control group receiving a placebo. A total of
60 dogs diagnosed with osteoarthritis were
recruited from veterinary clinics. Clinical diagnosis
of osteoarthritis based on radiographic evidence
and physical examination. Age between 5 and 12
years. Bod
y weight between 15 and 40 kg. Owners’
consent to participate in the study and adhere to
the protocol. Concurrent severe systemic illness.
Recent surgery or injury affecting mobility. Current
use of other dietary supplements or medications
influencing joint health, except for NSAIDs, which
were allowed if used consistently before the trial.
Dogs were randomly assigned to either the
treatment group or the placebo group using a
computer-generated randomization schedule. Both
the veterinarians administering the treatment and
the owners were blinded to the group assignments.
The treatment group received a combination of
dietary supplements containing: Glucosamine
hydrochloride: 500 mg, Chondroitin sulfate: 400
mg, Omega-3 fatty acids (EPA and DHA): 300 mg,
MSM (methylsulfonylmethane): 200 mg, Vitamin E:
50 IU. The placebo group received an identical-
looking supplement without the active ingredients.
Both treatments were administered orally once
daily with food.
THE USA JOURNALS
THE AMERICAN JOURNAL OF VETERINARY SCIENCES AND WILDLIFE DISCOVERY
(ISSN
–
2689-0968)
VOLUME 06 ISSUE04
9
https://www.theamericanjournals.com/index.php/tajvswd
Owners completed the CBPI to evaluate pain
severity and pain interference in daily activities.
Conducted by a blinded veterinarian to assess joint
pain, swelling, and range of motion. Objective
measurement of gait parameters using a pressure-
sensitive walkway to quantify changes in weight-
bearing and stride length. A standardized
questionnaire evaluated the dog's overall activity
level, willingness to exercise, and quality of life.
Levels of C-reactive protein (CRP) and other
inflammatory markers were measured at baseline,
6 weeks, and 12 weeks.
THE USA JOURNALS
THE AMERICAN JOURNAL OF VETERINARY SCIENCES AND WILDLIFE DISCOVERY
(ISSN
–
2689-0968)
VOLUME 06 ISSUE04
10
https://www.theamericanjournals.com/index.php/tajvswd
THE USA JOURNALS
THE AMERICAN JOURNAL OF VETERINARY SCIENCES AND WILDLIFE DISCOVERY
(ISSN
–
2689-0968)
VOLUME 06 ISSUE04
11
https://www.theamericanjournals.com/index.php/tajvswd
Data were analyzed using statistical software.
Changes from baseline to the end of the study in
primary outcome measures were compared
between the treatment and placebo groups using
paired t-tests or non-parametric equivalents as
appropriate. A p-value of less than 0.05 was
considered statistically significant. The study was
conducted following ethical guidelines for animal
research and was approved by an institutional
animal care and use committee. Informed consent
was obtained from all dog owners before
participation.
By
employing
a
rigorous
methodology, this study aimed to provide robust
evidence on the effectiveness of dietary
supplements in managing osteoarthritis in dogs,
potentially offering a new avenue for enhancing the
well-being of affected canine patients.
The significant improvements in pain, mobility,
and quality of life observed in the treatment group
suggest that dietary supplements can be a valuable
component of a comprehensive OA management
plan for dogs. These supplements offer a favorable
safety profile, with minimal adverse effects
reported, making them an attractive option for
long-term use. Reducing reliance on NSAIDs, which
can have significant side effects, especially with
prolonged use, is another important consideration.
The positive impact on inflammatory markers,
such as CRP, further supports the role of these
supplements in modulating the underlying
inflammatory processes in OA. This anti-
inflammatory effect may not only alleviate
symptoms but also slow disease progression,
offering long-term benefits for affected dogs.
RESULTS
Out of the 60 dogs initially enrolled, 57 completed
the study (treatment group: 29; placebo group: 28).
Three dogs were withdrawn due to non-
compliance with the protocol or unrelated health
issues.
The
demographic
and
baseline
characteristics of the dogs in both groups were
comparable, with no significant differences in age,
weight, severity of osteoarthritis, or baseline pain
and mobility scores. The treatment group showed
a significant reduction in pain severity scores from
baseline to week 12 (mean reduction: 2.1 points; p
< 0.01). The placebo group had a smaller, non-
significant reduction in pain severity (mean
reduction: 0.8 points; p > 0.05). Pain interference
scores in the treatment group also significantly
decreased (mean reduction: 2.4 points; p < 0.01),
while the placebo group showed no significant
change (mean reduction: 0.7 points; p > 0.05).
Dogs in the treatment group exhibited significant
improvements in joint pain and range of motion
(mean improvement: 3.5 points on a 10-point
scale; p < 0.01). The placebo group showed
minimal changes (mean improvement: 1.2 points;
p > 0.05). Treatment group dogs demonstrated
significant improvements in weight-bearing on the
affected limbs and increased stride length (p < 0.01
for both measures). The placebo group showed no
significant changes in gait parameters (p > 0.05).
Owners of dogs in the treatment group reported
significant improvements in overall activity level,
willingness to exercise, and quality of life (mean
improvement: 3.8 points on a 10-point scale; p <
0.01). In the placebo group, owner assessments
showed minimal changes (mean improvement: 1.1
points; p > 0.05). Dogs in the treatment group had
a significant reduction in C-reactive protein (CRP)
levels from baseline to week 12 (mean reduction:
15%; p < 0.01). The placebo group showed no
significant change in CRP levels (mean reduction:
2%; p > 0.05). No serious adverse events were
reported in either group. Minor gastrointestinal
upset was noted in three dogs from the treatment
group, which resolved without intervention.
The findings of this study indicate that dietary
supplements containing glucosamine, chondroitin
sulfate, omega-3 fatty acids, MSM, and vitamin E
significantly improved pain, mobility, and quality
of life in dogs with osteoarthritis. The treatment
group showed substantial reductions in pain
severity and interference, enhanced joint function,
improved gait, and decreased inflammatory
markers compared to the placebo group. These
results support the potential role of dietary
supplements as an effective adjunctive therapy in
managing osteoarthritis in dogs.
THE USA JOURNALS
THE AMERICAN JOURNAL OF VETERINARY SCIENCES AND WILDLIFE DISCOVERY
(ISSN
–
2689-0968)
VOLUME 06 ISSUE04
12
https://www.theamericanjournals.com/index.php/tajvswd
DISCUSSION
The results of this study demonstrate that dietary
supplements containing glucosamine, chondroitin
sulfate, omega-3 fatty acids, MSM, and vitamin E
can significantly improve the clinical symptoms of
osteoarthritis (OA) in dogs. These findings support
the growing div of evidence that nutritional
interventions can play a critical role in managing
OA, providing a safer and effective alternative or
adjunct to traditional pharmacological treatments.
Our findings are consistent with previous studies
that have highlighted the benefits of glucosamine
and chondroitin sulfate in supporting joint health
and reducing OA symptoms in dogs. For instance,
McCarthy et al. (2007) found that a combination of
glucosamine and chondroitin sulfate significantly
improved pain and mobility in dogs with OA over a
six-week period. Similarly, a study by Moreau et al.
(2003) reported improvements in weight-bearing
and joint function in dogs treated with these
supplements.
The addition of omega-3 fatty acids, MSM, and
vitamin E in our study likely contributed to the
enhanced anti-inflammatory effects and overall
joint support observed. Omega-3 fatty acids have
been shown to reduce the production of pro-
inflammatory cytokines, thereby decreasing
inflammation and pain associated with OA. MSM is
believed to support joint health through its anti-
inflammatory and antioxidant properties, while
vitamin E provides additional antioxidant support,
potentially protecting joint tissues from oxidative
damage.
The beneficial effects of the dietary supplements
observed in this study can be attributed to their
combined mechanisms of action. Glucosamine and
chondroitin sulfate are key components of cartilage
matrix and have been shown to promote cartilage
repair and reduce degradation. Omega-3 fatty acids
help modulate inflammatory responses, which is
crucial in managing chronic conditions like OA.
MSM contributes to the reduction of inflammatory
mediators and oxidative stress, further supporting
joint health. Vitamin E, as an antioxidant, helps
protect joint tissues from oxidative damage, which
is often exacerbated in OA.
The sample size, although adequate to demonstrate
significant effects, was relatively small. Larger-
scale studies are needed to confirm these findings
and to explore the effects of different dosages and
combinations of dietary supplements. Additionally,
the study duration was limited to 12 weeks; longer-
term studies are necessary to assess the sustained
benefits and potential long-term safety of these
supplements. By reducing pain, enhancing
mobility, and improving overall quality of life, these
supplements offer a promising adjunctive therapy
for canine OA. Incorporating dietary supplements
into the standard treatment protocol could help
veterinarians and pet owners provide more
comprehensive and effective care for dogs
suffering from this debilitating condition.
CONCLUSION
This study provides strong evidence supporting
the efficacy of dietary supplements in managing
osteoarthritis (OA) in dogs. The combination of
glucosamine, chondroitin sulfate, omega-3 fatty
acids, MSM, and vitamin E significantly improved
pain, mobility, and quality of life in affected dogs,
with minimal adverse effects. These findings
suggest that dietary supplements can serve as a
valuable adjunctive therapy in the comprehensive
management of canine OA.
The significant improvements in pain reduction,
enhanced
joint
function,
and
decreased
inflammation observed in the treatment group
underscore the potential of these supplements to
complement or even reduce reliance on traditional
pharmacological treatments, such as NSAIDs,
which are often associated with side effects during
long-term use. By targeting multiple mechanisms
involved in OA pathophysiology
—
such as cartilage
repair, inflammation modulation, and oxidative
stress reduction
—
these supplements offer a
holistic approach to managing the condition.
The study also highlights the importance of a
multifaceted treatment strategy for OA, one that
includes not only pharmacological interventions
but also nutritional support, physical therapy, and
weight management. The integration of dietary
supplements into routine veterinary care can
THE USA JOURNALS
THE AMERICAN JOURNAL OF VETERINARY SCIENCES AND WILDLIFE DISCOVERY
(ISSN
–
2689-0968)
VOLUME 06 ISSUE04
13
https://www.theamericanjournals.com/index.php/tajvswd
enhance the overall well-being of dogs suffering
from OA, providing them with a better quality of
life.
However, further research with larger sample sizes
and longer study durations is needed to confirm
these findings and to determine the optimal
formulations and dosages of dietary supplements
for canine OA. Future studies should also explore
the biochemical mechanisms underlying the
observed benefits, as well as the potential long-
term safety and efficacy of these supplements. In
conclusion, dietary supplements represent a
promising and safe addition to the therapeutic
arsenal for managing osteoarthritis in dogs. By
improving joint health and reducing pain and
inflammation, these supplements can significantly
enhance the quality of life for dogs with OA,
offering hope for better long-term outcomes in
managing this chronic and debilitating condition.
REFERENCES
1.
Abdelouahab N. & Heard C. (2008) Effect of the
major
glycosidesof
Harpagophytum
procumbens (Devil's Claw) on epidermal cy-
clooxygenase-2 (COX-2) in vitro. Journal of
Natural Products, 71,746
–
749.
2.
Abdurhman
S.A.
(2003)
Radiographic
osteoarthritis and serum choles-terol. Saudi
Medical Journal, 24, 745
–
747.
3.
Aggarwal B.B. (2007) Signalling pathways of
the TNF superfamily: Adouble-edged sword.
Immunology 3, 744
–
756.
4.
Aghazadeh-Habashi A. & Jamali F. (2011) The
glucosamine controversy;a pharmacokinetic
issue.
Journal
of
Pharmacy
and
PharmaceuticalSciences, 14, 264
–
273.
5.
Ahangarpour A., Heidari H., Mard S.A.,
Hashemitabar M. & KhodadadieA. (2014)
Progesterone and cilostazol protect mice
pancreatic isletsfrom oxidative stress induced
by hydrogen peroxide. Iranian Journalof
Pharmaceutical Research, 13, 937
–
944.
6.
Anderson, K. L., Neill, D. G., Brodbelt, D. C.,
Churc, D. B., Meeson, R. L.,Sargan, D., Summers,
J. F., Zulch, H., & Collins, L. M. (2018).
Prevalence,duration and risk factors for
appendicular
osteoarthritis
in
a
UK
dogpopulation under primary veterinary care.
Scientific Reports, 8, 5641.
7.
Aragon C.L., Hofmeister E.H. & Budsberg S.C.
(2007) Systematic reviewof clinical trials of
treatments for osteoarthritis in dogs. Journal of
theAmerican Veterinary Medical Association,
230, 514
–
521.
8.
Barre D.E. (2001) Potential of evening
primrose, borage, blackcurrant and fun-gal oils
in human health. Annals of Nutrition and
Metabolism, 45, 47
–
57.
9.
Berge, R. K., Ramsvik, M. S., Bohov, P., Svardal,
A., Nordrehaug, J. E.,Rosturp, E., Bruheim, I., &
Bjørndal, B. (2015). Krill oil reduces
plasmatriacylglycerol level and improves
related lipoprotein particle concen-tration,
fatty acid composition and redox status in
healthy young adults- a pilot study. Lipids in
Health and Disease, 14, 163.
10.
Bessa Pereira, C., Gomes, P. S., Costa-Rodrigues,
J., Almeida Palmas,R., Vieira, L., Ferraz, M. P.,
Lopes, M. A., & Fernandes, M. H. (2012).
